Current treatments cannot reverse macular degeneration, but they can slow it or stop it from getting worse

Macular degeneration damages the light-sensitive cells in the macula, the part of your retina that handles sharp central vision. Once those cells die, they do not grow back. No medication, surgery, or therapy currently restores vision that is already lost. What treatment does instead is prevent further cell death—which is why catching the disease early and starting treatment quickly matters so much.

The type of macular degeneration you have determines what is possible. Wet macular degeneration (also called neovascular) can sometimes be slowed or stabilized with injections into the eye or laser treatment. Dry macular degeneration, which is far more common, has fewer treatment options, though certain vitamins and lifestyle changes may slow progression in some people. Neither type can be cured or reversed.

Key Takeaways

  • Dead retinal cells cannot be restored, so vision already lost to macular degeneration will not come back with any current treatment.
  • Wet macular degeneration can sometimes be slowed with anti-VEGF injections (bevacizumab, ranibizumab, aflibercept) or photodynamic therapy, but results depend on how early treatment starts.
  • Dry macular degeneration progresses more slowly than wet, and certain vitamin combinations (AREDS formula) may reduce the risk of progression in intermediate and advanced stages.
  • The goal of all current treatment is to preserve remaining vision, not recover lost vision, which is why early detection through regular eye exams matters.

How wet macular degeneration treatment works

Wet macular degeneration happens when abnormal blood vessels grow under the macula and leak fluid or blood. This damages cells quickly—sometimes in weeks. Anti-VEGF injections are the main treatment. These drugs block a protein called vascular endothelial growth factor, which signals the body to grow new blood vessels. The three drugs used are bevacizumab (Avastin), ranibizumab (Lucentis), and aflibercept (Eylea). All three are injected directly into the eye, usually once a month for the first few months, then spaced out based on how you respond.

These injections can stop the bleeding and leaking, which halts vision loss. In some cases—roughly one in four people—vision actually improves slightly, though this is not reversal. It is stabilization of remaining cells plus some reduction in swelling that was blurring vision. Most people who start treatment early keep their current vision. Those who start late, after significant damage has already happened, are less likely to see improvement.

Photodynamic therapy is a second option for wet macular degeneration, though it is used less often now. A light-activated drug is injected into your arm, travels to the abnormal blood vessels in your eye, and is then activated by a laser. This destroys the vessels. It works best for certain types of wet macular degeneration and is sometimes combined with anti-VEGF injections.

What dry macular degeneration treatment can and cannot do

Dry macular degeneration accounts for about 90 percent of all macular degeneration cases. It develops when the macula gradually thins and drusen (yellow deposits) accumulate under the retina. There is no injection or laser treatment that reverses this. The main evidence-based approach is the AREDS formula, a specific combination of vitamins and minerals studied in large clinical trials.

The original AREDS study found that people with intermediate or advanced dry macular degeneration who took high-dose vitamins C and E, zinc, copper, and lutein reduced their risk of progression to advanced disease by about 25 percent over five years. A follow-up study, AREDS2, tested whether adding omega-3 fatty acids or zeaxanthin helped further. The results were modest. The formula does not stop progression entirely and does not work for people with early-stage disease.

Other treatments under research include stem cell therapy and gene therapy, but neither is yet approved for routine use. Clinical trials are ongoing, and some may eventually show promise, but they are not available now as standard treatment.

Why early detection changes what is possible

The difference between starting treatment at the first sign of wet macular degeneration and starting months later is substantial. Early treatment can preserve most or all of your remaining central vision. Late treatment often cannot recover what has already been lost. This is why eye exams that include dilated retinal exams matter, especially if you are over 60 or have a family history of macular degeneration.

If you notice a sudden change in your vision—straight lines looking wavy, a dark spot in the center of your vision, or colors looking different—contact an eye doctor the same day if possible. Do not wait for an appointment weeks away. Wet macular degeneration can cause significant damage in days.

What you can control to slow progression

You cannot reverse macular degeneration, but you can influence how fast it progresses. Smoking accelerates dry macular degeneration and worsens outcomes in wet macular degeneration. If you smoke, stopping is the single most effective thing you can do. High blood pressure and high cholesterol also speed progression, so managing these through medication and lifestyle matters.

A diet rich in leafy greens (spinach, kale), fish high in omega-3 fatty acids, and nuts may slow progression, though the evidence is stronger for the AREDS vitamin formula than for diet alone. Protecting your eyes from bright sunlight with UV-blocking sunglasses may also help, though this is preventive rather than treatment.

Regular eye exams—at least once a year if you have macular degeneration, more often if your doctor recommends it—let you catch changes early. Some people use an Amsler grid at home to monitor their own vision between appointments. This is a simple grid of lines you look at daily; if lines start looking wavy or a spot appears, you contact your eye doctor immediately.

Living with vision loss when treatment cannot restore it

If macular degeneration has already caused vision loss that treatment cannot reverse, low-vision rehabilitation can help you adapt. This includes learning to use magnifying devices, adjusting lighting in your home, reorganizing your space, and using screen-reading software on computers. An occupational therapist or low-vision specialist can assess what would help most in your daily life.

Many people with macular degeneration retain peripheral vision—they lose central vision but can still see the edges of their visual field. Learning to use this peripheral vision, called eccentric viewing, takes practice but allows many people to continue reading, cooking, and other tasks with the right tools and training.

Frequently Asked Questions

Can vitamins reverse macular degeneration?

No. The AREDS formula slows progression in intermediate and advanced dry macular degeneration, but it does not reverse damage or restore lost vision. It reduces the risk of worsening, not the disease itself.

What if I start treatment very early—can I avoid vision loss entirely?

Early treatment of wet macular degeneration can prevent most vision loss if caught before significant damage occurs. Dry macular degeneration progresses more slowly, so early detection gives you more time to start preventive measures like the AREDS formula and lifestyle changes.

Are there new treatments that might reverse macular degeneration in the future?

Stem cell therapy and gene therapy are in clinical trials, but neither is yet approved for standard use. Research is ongoing, and some approaches may eventually help, but there is no timeline for when or whether they will become available.

If I have lost vision in one eye, can treatment prevent it in the other?

Yes. If macular degeneration has affected one eye, your other eye is at risk. Regular monitoring and early treatment of any changes in the second eye can prevent similar vision loss there.